Articles From: Chemed Corporation to Present at the Oppenheimer 25th Annual Healthcare Conference to Chemtura Completes Sale of Its Agrochemicals Business to Platform Specialty Products Corporation


Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Oppenheimer 25th Annual Healthcare Conference on Wednesday, December 10, 2014, at approximately 8:00 a.m. (ET) at the Crowne Plaza Hotel in New York City.
Sign-up for Chemed Corporation to Present at the Oppenheimer 25th Annual Healthcare Conference investment picks
Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), the nation’s largest provider of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its third quarter ended September 30, 2014, versus the comparable prior-year period, as follows: Consolidated operating results: Revenue increased 5.1% to $358 million GAAP Diluted EPS increased 47.9% to $1.39 Adjusted Diluted EPS increased 8.8% to $1.48 VITAS segment operating results: Net Patient Revenue of $265 million, an increase of 4.5% Average Daily Census (ADC) of 14,639, an increase of 2.8% Admissions of 15,653,
Sign-up for Chemed Reports Third-Quarter 2014 Results investment picks
Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the third quarter ended September 30, 2014, on Thursday, October 30, 2014, following the close of trading on the New York Stock Exchange.
Sign-up for Chemed To Report Third-Quarter 2014 Earnings October 30, Related Conference Call To Be Held On October 31 investment picks
MIDLAND, Mich., Nov.
Sign-up for Chemical Financial Corporation Announces Fourth Quarter Cash Dividend investment picks
MIDLAND, Mich., Oct.
Sign-up for Chemical Financial Corporation Announces Third Quarter 2014 Earnings Conference Call investment picks
MIDLAND, Mich., Oct.
Sign-up for Chemical Financial Corporation Completes Acquisition of Northwestern Bancorp, Inc. investment picks
MIDLAND, Mich., Oct.
Sign-up for Chemical Financial Corporation Reports 2014 Third Quarter Operating Results investment picks
MIDLAND, Mich., Nov.
Sign-up for Chemical Financial Corporation to Partner With Monarch Community Bancorp, Inc. investment picks
Chemicals companies’ investment in digital technologies will rise sharply in the next three years, with cloud computing and big data analytics expected to generate the highest return on investment, according to a new survey by Accenture (NYSE:ACN). Almost all (94 percent) of the chemicals industry executives surveyed plan to increase their digital spend, with more than half (54 percent) projecting a significant rise.
Sign-up for Chemicals Companies to Increase Spend on Digital, with Cloud Computing and Analytics Expected to Generate the Highest ROI, Accenture Study Shows investment picks
Primary Endpoint Achieved; Statistically Significant Reduction in Urinary Protein Over 52 Weeks MOUNTAIN VIEW, Calif., Dec.
Sign-up for ChemoCentryx Announces Positive Results in Phase II Diabetic Nephropathy Trial With CCR2 Inhibitor CCX140 investment picks
MOUNTAIN VIEW, Calif., Sept.
Sign-up for ChemoCentryx Appoints Israel F. Charo, M.D., Ph.D., Senior Vice President of Research investment picks
SHIELD 4 Efficacy Results in Line With Positive Results in PROTECT-1, an Earlier Phase II Clinical Trial in Crohn's Disease MOUNTAIN VIEW, Calif., Oct.
Sign-up for ChemoCentryx Releases Phase III SHIELD 4 Clinical Results in Patients With Crohn's Disease investment picks
MOUNTAIN VIEW, Calif., Nov.
Sign-up for ChemoCentryx Reports Third Quarter 2014 Financial Results and Provides Corporate Update investment picks
MOUNTAIN VIEW, Calif., Oct.
Sign-up for ChemoCentryx to Hold Third Quarter 2014 Financial Results Conference Call on Wednesday, November 5, 2014 investment picks
MOUNTAIN VIEW, Calif., Nov.
Sign-up for ChemoCentryx to Present at Two Upcoming Investor Conferences investment picks
In Vivo Data Also Show Synergistic Effect of Combination Therapy With CCX507 and Approved Anti-Integrin Antibody in Colitis Model MOUNTAIN VIEW, Calif., Oct.
Sign-up for ChemoCentryx's Orally Administered CCR9 Inhibitor, CCX507, Shown to be Well Tolerated and Effective in CCR9 Blockade in Phase I Study investment picks
2014/11/17
Chemtrade Logisitics Income Fund Announces C$100 Million Bought Deal Financing Canada NewsWire TORONTO , Nov.
Sign-up for Chemtrade Logisitics Income Fund Announces C$100 Million Bought Deal Financing investment picks
2014/12/5
Chemtrade Logistics Income Fund completes bought deal public offering of 5,405,000 trust units Canada NewsWire TORONTO , Dec.
Sign-up for Chemtrade Logistics Income Fund completes bought deal public offering of 5,405,000 trust units investment picks
2014/11/19
Chemtrade Logistics Income Fund Declares November Distribution Canada NewsWire TORONTO , Nov.
Sign-up for Chemtrade Logistics Income Fund Declares November Distribution investment picks
2014/10/22
Chemtrade Logistics Income Fund Declares October Distribution Canada NewsWire TORONTO , Oct.
Sign-up for Chemtrade Logistics Income Fund Declares October Distribution investment picks
2014/9/19
Chemtrade Logistics Income Fund declares September distribution Canada NewsWire TORONTO , Sept.
Sign-up for Chemtrade Logistics Income Fund declares September distribution investment picks
PHILADELPHIA, Dec.
Sign-up for Chemtura Announces Final Results of Tender Offer investment picks
PHILADELPHIA, Dec.
Sign-up for Chemtura Announces Preliminary Results of Tender Offer investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Chemed Corporation to Present at the Oppenheimer 25th Annual Healthcare Conference to Chemtura Completes Sale of Its Agrochemicals Business to Platform Specialty Products Corporation
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent